Do Ambien (zolpidem) or Adderall (amphetamine and dextroamphetamine) have ototoxicity as an adverse effect?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Neither Ambien (zolpidem) nor Adderall (amphetamine/dextroamphetamine) is typically associated with ototoxicity as an adverse effect. Ototoxicity, which refers to damage to the inner ear or auditory nerve leading to hearing loss or balance problems, is not a commonly reported side effect for these medications. Ambien is a sedative-hypnotic medication used for short-term treatment of insomnia, with common side effects including drowsiness, dizziness, headache, and potential for dependence. Adderall is a stimulant used to treat ADHD and narcolepsy, with common side effects including increased heart rate, elevated blood pressure, insomnia, decreased appetite, and anxiety.

Key Points to Consider

  • Medications that are known to be ototoxic typically include certain antibiotics (like aminoglycosides) 1, chemotherapy drugs (like cisplatin), loop diuretics (like furosemide), and high doses of aspirin or NSAIDs.
  • The provided evidence 1 discusses ototoxicity in the context of aminoglycoside antibiotics, which is not relevant to Ambien or Adderall.
  • If you're experiencing hearing changes while taking either Ambien or Adderall, you should consult your healthcare provider as this could be related to another cause or an uncommon reaction that should be evaluated.

Important Considerations for Ototoxicity

  • Ototoxicity is a significant concern with certain medications, particularly aminoglycoside antibiotics, as it can lead to permanent hearing loss or balance problems 1.
  • Regular audiometric testing is recommended for patients receiving ototoxic medications to monitor for signs of hearing loss or vestibular disturbances 1.

From the Research

Ototoxicity of Ambien and Adderall

  • There is no direct evidence in the provided studies that Ambien (zolpidem) or Adderall (amphetamine and dextroamphetamine) have ototoxicity as an adverse effect 2, 3, 4, 5, 6.
  • The studies primarily discuss ototoxicity associated with other classes of drugs, such as diuretics, anti-inflammatory agents, antineoplastic agents, aminoglycoside antibiotics, and certain chemicals 2, 5.
  • Some studies mention the importance of monitoring for ototoxicity and the challenges in diagnosis and treatment 3, 4.
  • One study identified potential ototoxic adverse drug reactions for certain drugs, including hydroxyzine and sucralfate, but did not mention Ambien or Adderall 6.

Classes of Drugs with Known Ototoxicity

  • Aminoglycoside antibiotics 2, 4, 5
  • Antineoplastic agents 2, 4
  • Diuretics 2, 5
  • Anti-inflammatory agents 2
  • Loop diuretics 4, 5
  • Calcium channel blockers 4
  • Non-steroidal anti-inflammatory drugs 4
  • Antimalarial drugs 4, 5
  • Salicylates 4, 5

Importance of Monitoring and Prevention

  • Monitoring for ototoxicity is crucial in preventing permanent hearing loss and balance impairment 3, 4.
  • Early detection of toxicity through prospective ototoxicity monitoring allows for consideration of treatment modifications to minimize or prevent permanent hearing loss and balance impairment 3.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Drug-induced ototoxicity. Pathogenesis and prevention.

Medical toxicology and adverse drug experience, 1989

Research

Ototoxicity: A Challenge in Diagnosis and Treatment.

Journal of audiology & otology, 2018

Research

Ototoxicity: etiology and issues.

The Journal of family practice, 1983

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.